Search
Black Diamond Therapeutics Inc
BDTXAdd to Watchlist
1.690USD
-0.025-1.46%
Close 07-31 16:00（ET）Quotes delayed by 15 min
96.84MMarket Cap
LossP/E TTM
Black Diamond Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Black Diamond Therapeutics Inc is 6.65, ranking 274 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.22, which is -1500.36% below the recent high of 31.04 and -113.02% above the recent low of -4.72.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.